-
Pfizer: No Buy Signal After The Dip
Post on 9/29/16
-
Johnson & Johnson: Buying The Dips Beats The Drips - Timing Not An Issue
Post on 9/29/16
-
Better Buy: Johnson & Johnson vs. AbbVie
Post on 9/29/16
-
Tabula Rasa HealthCare Prices IPO
Post on 9/29/16
-
Foamix Pharmaceuticals Prices $57 Million Follow-on Offering of Ordinary Shares
Post on 9/28/16
-
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing Agreement and Bi-Specific Antibody Collaboration
Post on 9/28/16
-
DermaMed Solutions Celebrates Fifth Anniversary of Ownership of Mark Pinsley and Ginger Hodulik
Post on 9/28/16
-
The 3 Best-Run Companies in the Healthcare Sector
Post on 9/28/16
-
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Post on 9/28/16
-
Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company
Post on 9/28/16
-
Pfizer's 9% Decline Gives Dividend Investors Buying Opportunity
Post on 9/28/16
-
3 Biotechs With Potential Big-Time Upside
Post on 9/27/16
-
Cantel Medical Expands its Direct Sales Operations in Canada
Post on 9/26/16
-
Pharmacy Times Honors Pharmacists During American Pharmacists Month
Post on 9/26/16
-
Cambrex To Acquire PharmaCore
Post on 9/26/16
-
Snippet Roundup: Firsts For Chinese CAR Companies, Setbacks For J&J And Mast
Post on 9/26/16
-
3 Bold Bets on the Future of Biotechnology
Post on 9/26/16
-
Biotech: What's Next For M&A?
Post on 9/26/16
-
Marijuana Could Be the Key to Overcoming America's Opioid Epidemic
Post on 9/26/16
-
Behavioral Health Home Plus Wins 2016 Recognition of Excellence in Wellness from SAMHSA's Program
Post on 9/25/16
-
The Children's Hospital of Philadelphia Announces Major $50 Million Pediatric Genetics Research and Patient Care Initiative
Post on 9/25/16
-
Qfix Announces Launch of Symphony Patient Transport System
Post on 9/25/16
-
Roka Bioscience Completes Private Placement of Preferred Stock and Warrants
Post on 9/22/16
-
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Post on 9/22/16
-
The Most Exciting Drug in Celgene's Pipeline
Post on 9/22/16